未找到相关数据
SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer
被引：8
作者：
Aftimos, P. G.
van Herpen, C. M.
Mommers, E. C.
Koper, N. P.
Goedings, P.
Oesterholt, M.
Awada, A.
Desar, I. M.
Lim, J.
Dean, E.
Rolfo, C.
Macpherson, I.
Banerji, U.
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
[2] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[3] Synthon Biopharmaceut BV, Nijmegen, Netherlands
[4] Inst Canc Res & Royal Marsden, London, England
[5] Christie NHS Fdn Trust, Manchester, Lancs, England
[6] Univ Antwerp Hosp, Edegem, Belgium
[7] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
来源：
关键词：
D O I：
10.1158/1538-7445.SABCS16-P6-12-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-12-02
引用
收藏
页数：2
相关论文